Dr. Fonseca on Pivotal Ongoing Trials in Multiple Myeloma

Multiple Myeloma: Looking Ahead | Dr. Rafael Fonseca (5/5) | The Patient StoryПодробнее

What is Multiple Myeloma? | Dr. Rafael Fonseca, M.D. | The Patient StoryПодробнее

Rafael Fonseca discusses MOA and Its Impact on Myeloma TreatmentПодробнее

Multiple Myeloma and Clinical Trials: What You Should Know | For Patients and CaregiversПодробнее

HealthTree Podcast for Multiple Myeloma: Dr. Rafael Fonseca, Mayo ScottsdaleПодробнее

The Ongoing Role of Transplant in Multiple MyelomaПодробнее

Clinical Trials for Multiple Myeloma Patients (Selinexor, CAR T Cell) | Donna’s StoryПодробнее

Dr. Voorhees on Pivotal Ongoing Trials in Multiple MyelomaПодробнее

The current and future management of myeloma in the second-lineПодробнее

Dr. Fonseca on FISH Testing in Patients With MyelomaПодробнее

Rafael Fonseca, MD, discusses maintenance regimens for multiple myelomaПодробнее

Final Thoughts on Modern Treatment of MyelomaПодробнее

MRD in multiple myeloma: determining responseПодробнее

Minimal residue disease (MRD) in multiple myelomaПодробнее

Clinical Trials in Multiple MyelomaПодробнее

Dr. Rafael Fonseca: A discussion about the utility of gene expression in Multiple MyelomaПодробнее

Next steps in myeloma: quadruplets, immunotherapy, and replacing transplantПодробнее

MCRT Phoenix 2017: The Basics of Myeloma Genetics by Rafael Fonseca, MDПодробнее

Addressing the disparity in ethnic variation in UK-based clinical trials for multiple myelomaПодробнее